Cooperative Agreement U2GGH000291

The University of South Florida (USF) received a $389,527 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining strategies and contextual factors that optimize the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention in Kenya. The key products and services to be delivered through this two-year project include: Identifying implementation strategies and contextual factors that...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

The U.S. Department of Health and Human Services' HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) awarded a $1,702,777.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on July 1, 2025. The grant supports UCSF's comprehensive efforts to prevent, diagnose, and address HIV transmission through targeted community-based interventions, with a focus on developing and implementing effective HIV prevention strategies for high-risk...

This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...

This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $680,644 to the University of Alabama at Birmingham (UAB) to evaluate the "Healthy Families-PREP" intervention. This intervention aims to promote the use of pre-exposure prophylaxis (PrEP) among periconception, pregnant, and postpartum women in rural Uganda to reduce HIV incidence. The 5-year project will first adapt the 3-session...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...

The project grant titled "PLANNING FOR IMPLEMENTATION OF A FAMILY-BASED INTERVENTION FOR PREVENTION OF HIV, SUBSTANCE USE, AND MENTAL HEALTH PROBLEMS AMONG HISPANIC YOUTH AT RISK: A COMMUNITY-ENGAGED APPROACH" is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $176,083 award, provided on September 22, 2025, supports the University of Miami in developing an implementation strategy package to facilitate the...

This Project Grant award of $962,973.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop and evaluate a comprehensive curriculum on HIV prevention and implementation science for pharmacy schools in the southern United States. The project, titled "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic through Collaboration with Pharmacy Schools," will be...

The Department of Health and Human Services National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center, also known as the Seattle Cancer Care Alliance, to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial across 20 pharmacies in Kenya. The goal of the project is to leverage telehealth to optimize the delivery of pre-exposure prophylaxis (PrEP) and...